XOMA Declares Quarterly Preferred Stock Dividends
20 juin 2023 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy
09 mai 2023 07h30 HE
|
XOMA Corporation
First quarter with incoming cashflows from two commercial assets Completed first royalty asset acquisition under new leadership EMERYVILLE, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- XOMA...
XOMA to Present at H.C. Wainwright BioConnect Investor Conference
26 avr. 2023 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty Aggregator, announced today Owen Hughes, Executive Chairman, and Brad Sitko, Chief...
XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio
30 mars 2023 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired the commercial payment and a portion of the milestone rights to IXINITY®...
XOMA Declares Quarterly Preferred Stock Dividends
21 mars 2023 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy
09 mars 2023 07h30 HE
|
XOMA Corporation
2022 was the first year with cash receipts from a commercial asset since becoming a royalty aggregator Ebopiprant royalty and milestone license acquisition gives XOMA the potential to earn up to $378...
XOMA to Present at 43rd Annual Cowen Health Care Conference
28 févr. 2023 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty Aggregator, announced today that Owen Hughes, Executive Chairman, and Brad Sitko, Chief...
XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 janv. 2023 19h00 HE
|
XOMA Corporation
EMERYVILLE, Calif., Jan. 06, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”), the Biotech Royalty Aggregator, today announced the Company has granted Owen Hughes,...
New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy
04 janv. 2023 07h30 HE
|
XOMA Corporation
Owen Hughes appointed Executive Chairman of the Board of Directors and Brad Sitko joins as Chief Investment Officer EMERYVILLE, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ:...
XOMA Declares Quarterly Preferred Stock Dividends
22 déc. 2022 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...